119-HR-8622 Journalist Public Summary

Headline Summary

A bipartisan bill to rebrand and simplify Medicare’s doctor pay‑for‑performance program, set predictable bonus/penalty rules, and send extra help to small, under‑resourced practices.

What It Does

In plain English: the bill would rename Medicare’s current Merit‑based Incentive Payment System (MIPS) to the Data‑driven Performance Payment System (DPPS) on January 1, 2027, and, beginning in 2028, apply simple, preset multipliers to a doctor’s annual Medicare payment update based on performance. It also caps how hard it is to earn a bonus for several years, protects patients from higher copays caused by these adjustments, and creates one‑time “investment” payments for small practices when the program generates net savings.

• Renames MIPS to DPPS in 2027, with a transition period to avoid confusion.
• From 2028 on, uses fixed adjustment factors: strong performers get a 1.25 multiplier; at‑threshold get 1.0; below‑threshold get 0.75; non‑reporters (treated as lowest score) get 0.5.
• If the base Medicare physician update for a year is negative, DPPS bonuses/penalties are not applied on top of that negative update.
• Requires Medicare to give clinicians timely, quarterly feedback (within 60 days of quarter‑end) on claims‑based measures; if timely feedback isn’t provided, the “below‑threshold” penalty doesn’t apply for those clinicians that year.
• “Hold harmless” for patients: deductibles and coinsurance are calculated as if no DPPS adjustment occurred, so patients’ cost‑sharing doesn’t rise because of DPPS.
• Performance threshold rules: through 2028–2033 (and longer if extraordinary circumstances persist), the threshold can’t exceed 75 points; GAO recommendations by December 31, 2029, help CMS set a new, data‑reliable threshold method after that, with an optional transition year.
• Budget neutrality continues: Medicare will scale down positive adjustments as needed so total bonuses don’t exceed total penalties.
• Creates “DPPS savings year” investment payments for small practices (generally ≤15 clinicians, with authority to prioritize rural/HPSA/medically underserved or low‑scoring practices) to improve care management, address patients’ social needs, upgrade EHRs, and participate in value‑based models.

Who’s For It

• Sponsors: Rep. Mariannette Miller‑Meeks (R‑IA) and Rep. Herbert Conaway (D‑NJ).
• Supporters’ case (as reflected in the text): clearer, preset bonuses/penalties; guardrails on scoring difficulty; quarterly feedback to clinicians; and targeted investments for small, rural, and underserved‑area practices when the program saves money.

Who’s Against It

No formal opposition is recorded yet at introduction. Potential concerns stakeholders may raise include:

• Even with simpler multipliers, performance scoring can still feel complex or unfair across specialties, small vs. large groups, and rural vs. urban settings.
• Budget‑neutrality means top performers’ bonuses can be scaled down, which may blunt incentives.
• Fixed multipliers (1.25/0.75/0.5) could create sharper winners and losers compared with a sliding scale.
• Capping the threshold at 75 points for several years could be viewed as too lenient (or, conversely, still too demanding) depending on how measures are set and risk‑adjusted.
• Quarterly feedback is helpful, but only for claims‑based measures; other categories may still lag.

What’s Next

As of April 30, 2026, H.R. 8622 was introduced and referred to the House Energy and Commerce Committee and the Ways and Means Committee. Next steps typically include committee hearings and potential amendments (“markups”). If approved, it would go to a House floor vote, then to the Senate, and finally to the President if both chambers pass the same bill.